Department of Pharma has launched a PLI scheme for the promotion of domestic manufacturing by setting up greenfield plants in four different target segments with a total outlay of Rs 6,940 crore for the period 2020-21 to 2029-30.
The hype around antibody-drug conjugates (ADCs) has been growing in recent years after big bucks deals and approvals from the likes of AstraZeneca/Daiichi and Immunomedics putting a spotlight on the approach.
Europe's drugs regulator on Friday recommended changing some terms of the conditional approval given to antiviral drug remdesivir as a COVID-19 treatment, to make clear the conditions under which it can be used.
We randomly assigned 870 patients who had resected stage III melanoma with BRAF V600E or V600K mutations to receive 12 months of oral dabrafenib (at a dose of 150 mg twice daily) plus trametinib (2 mg once daily) or two matched placebos.
In this double-blind trial, we randomly assigned 3730 patients with class II, III, or IV heart failure and an ejection fraction of 40% or less to receive empagliflozin (10 mg once daily) or placebo, in addition to recommended therapy. The primary outcome was a composite of cardiovascular death or hospitalization for worsening heart failure.
307, Building C, Shanghai Juke Biology Songjiang
Park No.5629 Beisong Highway, Songjiang District
Shanghai, China, 201611
Scan QR code to contact us via WeChat
Shanghai Up-Fluorochem Co., Ltd. (UP-F) . It was founded by Dr. from Shanghai Jiao Tong University and Zhejiang University, with sophisticated technical talents and advanced technology in the international fluorine chemical industry.
UP-F is an innovative modern industrial enterprise engaged in the R&D, production and application of fluorine-containing pharmaceuticals, pesticides and intermediates, fluorine-containing materials and intermediates and organic fluorine-containing blocks and catalysts.
Our company is committed to becoming the world's leading provider of integrated organic fluorine chemical technology solutions. Providing with High-quality fluorine-containing organic compounds for research and development or industrial use for customers who are widely distributed in academia and industry globally is one of our major mission. In addition, we provide comprehensive research and development supporting, such as cooperative development, commissioned development and other scientific research services.
Fluorine chemical technology development, new material product development, chemical technology solutions, and innovative business investment.
UP-F has established project cooperation with a number of university key laboratories and research institutions. And look forward to contributing to the global chemical and new materials technology industry. UP-F sincerely welcomes Chinese and foreign friends to come to conduct business, exchange technology and cooperation opportunities.